Satoru Taguchi Selected Research

Lymph Node Excision (Lymph Node Dissection)

4/2022	Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes.
1/2019	Re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoru Taguchi Research Topics

Disease

20	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2012
18	Carcinoma (Carcinomatosis) 12/2023 - 09/2013
16	Neoplasms (Cancer) 03/2024 - 07/2015
13	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2013
7	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 04/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2017
3	Sarcopenia 12/2023 - 06/2016
3	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2022 - 01/2020
2	Margins of Excision 01/2024 - 03/2023
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2023 - 10/2023
2	Pain (Aches) 10/2023 - 01/2023
2	Lymphatic Metastasis 01/2023 - 02/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2021
2	Testicular Neoplasms (Testicular Cancer) 04/2022 - 09/2011
2	Hydronephrosis 01/2022 - 10/2017
2	Chronic Renal Insufficiency 01/2022 - 02/2018
2	Melanoma (Melanoma, Malignant) 03/2019 - 01/2017
1	Disease Progression 10/2023
1	Leiomyosarcoma 07/2023
1	Hyperglycemia 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Overactive Urinary Bladder (Overactive Bladder) 01/2023
1	Frailty 10/2022
1	Ischemic Stroke 10/2022
1	Stroke (Strokes) 10/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2022
1	Hematuria 01/2022
1	Atherosclerosis 01/2022
1	Lower Urinary Tract Symptoms 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Ovarian Cysts (Ovarian Cyst) 01/2022
1	Cysts 05/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Adenocarcinoma 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 09/2020

Drug/Important Bio-Agent (IBA)

7	pembrolizumabIBA 12/2023 - 01/2021
7	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
4	AndrogensIBA 10/2023 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 01/2023 - 02/2016
4	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 09/2013
4	AlbuminsIBA 01/2021 - 02/2016
3	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2023
3	enfortumab vedotinIBA 01/2024 - 12/2023
3	Tolvaptan FDA Link 02/2022 - 01/2020
2	Proton Pump InhibitorsIBA 03/2024 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 01/2023
2	Xanthine DehydrogenaseIBA 01/2022 - 01/2021
2	GlobulinsIBA 01/2021 - 08/2020
2	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2015
2	talimogene laherparepvecIBA 03/2019 - 01/2017
2	C-Reactive ProteinIBA 09/2017 - 01/2017
1	avelumabIBA 12/2023
1	LigandsIBA 12/2023
1	PlatinumIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2023
1	Leuprolide (Lupron)FDA LinkGeneric 10/2023
1	Goserelin (Zoladex)FDA Link 10/2023
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2023
1	Hormones (Hormone)IBA 10/2023
1	Prednisolone (Predate)FDA LinkGeneric 10/2023
1	mirabegronIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 11/2022
1	Gemcitabine FDA Link 11/2022
1	Troponin T (Troponin T1)IBA 10/2022
1	LipidsIBA 10/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022
1	Collagen Type I (Type I Collagen)IBA 08/2022
1	N 30IBA 01/2022
1	AntibodiesIBA 01/2022
1	NivolumabIBA 01/2022
1	Cystatin CIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Melanins (Melanin)IBA 05/2021
1	SynaptophysinIBA 01/2021
1	Chromogranin AIBA 01/2021
1	cabazitaxel FDA Link 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	TEMPOIBA 09/2020

Therapy/Procedure

16	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 01/2014
9	Therapeutics 01/2024 - 10/2012
9	Drug Therapy (Chemotherapy) 12/2023 - 09/2013
8	Radiotherapy 01/2024 - 01/2015
6	Cystectomy 07/2023 - 01/2017
5	Nephroureterectomy 01/2022 - 02/2016
4	Castration 12/2023 - 01/2012
3	Transurethral Resection of Bladder 01/2022 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 11/2019
2	Adjuvant Chemotherapy 03/2023 - 10/2017
2	Immunotherapy 01/2023 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2019
2	Oncolytic Virotherapy 03/2019 - 01/2017
1	Hysterectomy 01/2022
1	Ovariectomy (Oophorectomy) 01/2022
1	Brachytherapy 09/2020